Ikapharmindo Putramas Tbk. vs Multifiling Mitra Indonesia Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 313.35B, 1.41M 24h volume), while Multifiling Mitra Indonesia Tbk. trades at Rp1,300 (market cap 984.86B). The key difference: Multifiling Mitra Indonesia Tbk. is far larger — about 3.1× Ikapharmindo Putramas Tbk.'s market cap. Which is the better fit depends on your goals.
| IKPM | MFMI | |
|---|---|---|
Market Cap | 313.35B | 984.86B |
Volume | 1.41M | — |
Lot | 14.1K | — |
Turnover | 271.25M | — |
Average Price | 192.33 | — |
Value | 271.25M | — |
Indicative Equilibrium Price | 186 | — |
Indicative Equilibrium Volume | 600 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.
Read more on MFMI →